Using Breathing Techniques to Ease Anxiety in ICU Patients Awaiting Heart Transplants
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHartford HealthCare
About this trial
The goal of this clinical trial is to learn whether a breathing-based relaxation technique called heart rate variability biofeedback (HRVB) can help reduce anxiety in adult patients who are in the intensive care unit (ICU) and waiting for a heart transplant. The main questions it aims to answer are:
Can HRVB reduce anxiety in patients awaiting heart transplantation in the ICU? Does HRVB help patients feel more in control of their emotions during this stressful time?
Participants will:
Complete a brief anxiety assessment before and after the intervention Participate in a guided HRVB session using a breathing device or app Learn how to use the technique on their own for future stress management
Eligibility criteria
Qualifiers
any gender
any race/ethnicity
≥18 years old with no upper limit
currently inpatient in the cardiac ICU, awaiting heart transplant
Disqualifiers
<18 years of age
active psychosis or delirium
current neurological problems (e.g., stroke) at time of enrollment that would interfere with the ability to complete the practice
on a ventilator at time of enrollment
Trial design
Treatments tested in this trial
- Heart Rate Variability Biofeedback (HRVB)
Treatment groups
60 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov